ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Comprehensive analysis of HDAC7 expression and its prognostic value in diffuse large B cell lymphoma: A review

Lu, Weiguo; Zhuang, Guangyan; Guan, Youmin; Li, Yongcong; Liu, Liujun; Xiao, Mingfeng*广州中医药大学; 1
Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries2023-11-10DOI: 10.1097/MD.0000000000034577
9阅读
引用收藏
分享

摘要

HDAC7 loss or dysregulation may lead to B cell-based hematological malignancies. This study aimed to explore the prognostic value of HDAC7 in patients with diffuse large B cell lymphoma (DLBCL). RNA sequencing data and clinical information for HDAC7 in DLBCL were collected from the cancer genome atlas database and analyzed using R software. Paired t and Mann-Whitney U tests were used to detect differences between DLBCL and adjacent normal tissues, and the pROC software package was used to generate receiver operator characteristic curves to detect cutoff values for HDAC7. Data from paraffin-embedded specimens from the 2 groups were used for validation of external immunohistochemical staining. The tumor immunity estimation resource and integrated repository portal for tumor immune system interactions databases were used to analyze the correlation between HDAC7 and DLBCL immune cell infiltration. Survival analysis of HDAC7 in patients with DLBCL was performed using the PrognoScan database. Compared with that in normal tissues, HDAC7 mRNA was overexpressed in DLBCL. The HDAC7 immunohistochemical staining scores of stage III and IV DLBCL patients were significantly lower than those of stage I and II DLBCL patients, which was associated with shorter overall survival and disease-specific survival. In addition, the higher expression of HDAC7 may play a role in the lower level of immune infiltration in DLBCL. Downregulation of HDAC7 expression was correlated with poor prognosis and immune infiltration in DLBCL patients.

学科与关键词

关键词
biomarkerdiffuse large B cell lymphomaHDAC7immune infiltrationprognosis
相关
加载中…
  • An Immune-Related Prognostic Classifier Is Associated with Diffuse Large B Cell Lymphoma Microenvironment
    Liang, Xiao-Jie; Fu, Rui-ying; Wang, He-nan; Yang, Jing; Yao, Na; Liu, Xin-di; Wang, Liang*Journal of Immunology Research, 2021, 2021: 5564568.被引 7
  • Identification and validation of hub genes in CD5-positive diffuse large B-cell lymphoma
    Yang, Ming; Niu, Xingjian; Yang, Xudong; Sun, Yutian; Su, Wenjia; Zhang, Jing; Wu, Qianjiang; Wang, Yiran; Zhang, Qingyuan*; Ji, Hongfei*Experimental Biology and Medicine, 2023, 248(17): 1469-1478.
  • Expression and Prognostic Value of Glucose Transporter 3 in Diffuse Large B Cell Lymphoma
    Xu, Yongpeng; Zhou, Xinglu; Zhang, Shuai; Nanding, Abiyasi; Xuan, Qijia*OncoTargets and Therapy, 2022, 15: 181-191.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries
发表日期
2023-11-10
卷期
第 102 卷, 第 45 期
页码
e34577
DOI
10.1097/MD.0000000000034577
语言
ENGLISH
成果收录
SCIE
资助标注
Guangdong Provincial Rural Science and Technology Project [KTP2020346]

作者

  • L

    Lu, Weiguo (第一作者)

    1 · guangzhou univ chinese med

  • Z

    Zhuang, Guangyan

    guangzhou univ chinese med

查看全部 6 位作者收起作者
  • G

    Guan, Youmin

    guangzhou univ chinese med

  • L

    Li, Yongcong

    guangzhou univ chinese med

  • L

    Liu, Liujun

    guangzhou univ chinese med

  • X

    Xiao, Mingfeng (通讯)

    1 · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417